$1.08
Today
as of Sep 4, 16:53 ET
Last 30 days
Recent Press Releases & News
Phio Pharmaceuticals Secures U.S. Notice of Allowance for INTASYL Composition Selectively Targeting BRD4 Protein with Compound PH-894
Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
Correction to Announcement Regarding Phio Pharmaceuticals Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
Overview
52-week range
$0.81
$4.19
8% of range
Avg surprise (last 2)
-33.3%
Avg reaction (last 2)
-2.6%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $-0.34 | $-0.24 | -41.7% | +17.1% | -0.9% | earnings |
| Thu Aug 14, 2025 | Jun/2025 | $-0.45 | $-0.36 | -25.0% | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $-0.41 | — | — | — | -4.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-1.54 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-3.62 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.47 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-10.25 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-13.27 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-3.15 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-4M | $-4M | — | $-3M | $-2M | $-2M | — | $-2M |
| Net income | $-4M | $-4M | — | $-2M | $-2M | $-2M | — | $-2M |
| EPS (diluted) | — | — | — | — | $-0.45 | $-0.41 | — | $-1.54 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $13M | $17M | $21M | $11M | $11M | $13M | $5M | $5M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $14M | $17M | $21M | $11M | $11M | $13M | $6M | $6M |
| Total assets | $14M | $17M | $21M | $12M | $11M | $13M | $6M | $6M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $2M | $950,000 | $1M | $2M | $1M | $1M | $1M | — |
| Total equity | $13M | $16M | $20M | $10M | $10M | $12M | $5M | $5M |
Implied volatility — last 90 days
No IV snapshots yet for PHIO.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.